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ABSTRACT 
Objective: To assess the correlation of glycosylated hemoglobin levels with fasting and postprandial glucose in South Indian type 2 diabetic 
patients. 
Methods: This retrospective observational study was carried out as per the protocol approved by the institutional ethics committee (IEC) and case 
records of patients (≥ 4 0 y old) diagnosed with type 2 diabetes mellitus (T2DM) and complications, that fasting blood sugar (FBS), postprandial 
blood sugar (PPBS) and HbA1c measured during previous follow-ups were included in the study. Statistical analyses were carried out using SPSS 
Ver.20 and p ≤ 0.05 were considered statistically significant.  
Results: Based on the study criteria, 633 case profiles were selected and enrolled in the study. Most of the patients were males 488 (77.1%) and the 
mean age of patients was 59.7 y (SD=9.6). The mean fasting glucose and postprandial glucose were 9.42 mmol/l (SD=4.2), 13.39 mmol/l (SD=5.2) 
respectively. Patients were suffering from different type of diabetes complications, and most of them had poor glycemic control as the mean HbA1c 
was found to be 8.7 % (SD=2.2). The FBS and PPBS were plotted against HbA1c values showed moderate correlation and the sensitivity, specificity, 
positive predictive value and negative predictive value of postprandial glucose level was better than the fasting blood glucose level. 
Conclusion: This present study showed that there is the significant correlation between PPBS and HbA1c values. Since PPBS is performed routinely, 
its interpretation in terms of long term glycemic control will help clinicians to tailor their therapeutic strategies. 
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INTRODUCTION 
Diabetes is a group of metabolic diseases characterized by elevated 
plasma glucose level [1]. 
Glucose intolerance and high level of blood glucose can eventually 
lead to other health problems. Uncontrolled diabetes can eventually 
lead to macrovascular and microvascular complication like 
nephropathy, retinopathy and neuropathy [2, 3]. 
Type 2 diabetes is associated with a marked increase in the fasting 
blood sugar (FBS), postprandial blood sugar (PPBS) and 
glycosylated hemoglobin A1C (HbA1c) level of the blood test [1, 4]. 
Optimal glycemic control is fundamental and still is the main therapeutic 
objective for the managing and prevention of target organ damage and 
other complications arising from diabetes that can impact on quality of 
life, morbidity and early death in these Patients [5-7]. Controlling FBS, 
PPBS and HbA1c is the strategy for achieving optimal glycemic 
control and preventing or reducing the risk of diabetic complications 
[8-11]. 
The glycosylated hemoglobin A1C (HbA1c), has become the gold 
standard for measuring chronic glycemic [12] and is the clinical 
marker for predicting and managing long-term complications, and 
any reduction in HbA1c is likely to reduce the risk of complications 
[13-16]. HbA1c is most commonly measured as an indicator of 
glycemic control during the preceding 2 to 3 mo because it 
comprises the majority of glycosylated hemoglobin and is the least 
affected by the recent fluctuations in blood glucose [17]. 
Many investigations have demonstrated the correlations between 
HbA1C levels, fasting blood sugar and postprandial blood sugar, 
although the effects were not significant [18, 19]. The elevated PPBS 
level has been associated with cardiovascular complications. [20] 
Control of FBS is necessary but usually insufficient for achieving 
optimal control of PPBS is essential for achieving recommended 
HbA1c goals [21]. 
Since during the consultation encounters FBS and PPBS was usually 
assessed and if this data could give an idea of the overall glycemic 
control of the patient, it would be relevant for monitoring patients. 
The present study was aimed to assess the correlation between 
Since fluctuations of fasting plasma glucose and postprandial could 
affect HbA1c [22], this study was performed to assess the 
correlation of glycosylated hemoglobin levels with fasting and 
postprandial glucose in South Indian type 2 diabetic patients. 
MATERIALS AND METHODS 
This retrospective observational study was carried out as per the 
protocol approved by the institutional ethics committee (IEC: 
561/2015) and conducted based on in-patient and out-patient 
medical records of patients admitted in Kasturba Hospital, Manipal. 
Case records of patients (≥ 40 y old) diagnosed with type 2 diabetes 
mellitus (T2DM) and complications, that fasting blood sugar (FBS), 
postprandial blood sugar (PPBS) and HbA1c measured during 
previous follow-ups were included into the study. All case profile 
meeting study criteria during the 6-month period of review were 
included.  
All demographic and clinical data of patients were collected and 
documented in a suitably designed case report form. Patients were 
divided into two groups according to the HbA1c level as a good 
control group (HbA1c ≤7%, FBS<6.94 mmol/l, PPBS<11.02 mmol/l) 
and poor control group (HbA1c>7%, FBS>6.94 mmol/l, PPBS>11.02 
mmol/l).  
Statistical analyses were carried out using SPSS Ver.20 and p ≤ 0.05 
were considered statistically significant. All demographic data were 
expressed using descriptive statistics. Mean HbA1C values were 
compared with demographic variables using student t-test and one-
way ANOVA. The correlation between the parameters was carried 
out using Pearson’s correlation. 
Regression analysis was carried out relation between FBS, PPBS and 
HbA1c by dividing the groups into good and poor control. 
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Based on the study criteria, 633 case profiles were selected and 
enrolled in the study. The mean age of patients was 59.7 y (SD=9.6) 
and mean duration of diabetes illness was 12.6 y (SD=7.8). The mean 
fasting glucose and postprandial glucose were 9.42 mmol/l (SD=4.2), 
13.39 mmol/l (SD=5.2) respectively. Most of the patients had poor 
glycemic control as the mean HbA1c was found to be 8.7 % (SD=2.2). 
Most of the patients were males 488 (77.1%). Patients were 
suffering from different type of diabetes complications. The majority 
of patients, 171 (27%) had peripheral neuropathy as a complication 
and 155 (24.5%) diabetic retinopathy. Most of patients 506 (79.9%) 
had at least one diabetic complication and 127 (20%) of patients had 
two complications. The higher mean HbA1c values were observed in 
patients with two complications (table 1). 
When prescription patterns were studied, most of the patients 401 
(63.3%) used insulin or oral anti-diabetics as monotherapy to 
control their blood glucose level and a combination of insulin and 
oral hypoglycemic agents was prescribed for 232 (36.7%) patients 
to manage their condition (table 1). 
  
Table 1: HbA1c values according to demographic factors 
Variable Total patient N (%) HbA1c (mean±SD) p value 
Gender    
0.013*  Male 488 (77.1) 8.6±2.1 
 Female 145 (22.9) 9.1±2.4 
Type of complication    
 Ketoacidosis 22 (3.5) 8.5±2.2 0.175 
 Nephropathy 69 (10.9) 8.5±2.1 
 Retinopathy 155 (24.5) 9±2.4 
 Neuropathy 89 (14.1) 8.9±2.3 
 Peripheral 171 (27) 8.5±2.1 
 Nephropathy+Neuropathy 7 (1.1) 9.6±1.9 
 Neuropathy+Peripheral 4 (0.6) 8.4±2.5 
 Neuropathy+Retionapthy 10 (1.6) 10±0.9 
 Nephropathy+Peripheral 18 (2.8) 8.5±1.9 
 Nephropathy+Retionapthy 83 (13.1) 8.3±2.1 
 Peripheral+Retionapthy 5 (0.8) 8.7±3.3 
Type of medication    
 OHA 145(22.9) 7.7±1.7  <0.001* 
 Insulin 256(40.4) 8.8±2.2 
 Insulin+OHA 232(36.7) 9.2±2.3 
OHA: Oral hypoglycemic agent; *p value<0.05(significant) 
 
The FBS and PPBS were plotted against HbA1C values showed 
moderate correlation. Pearson’s correlation co-efficient was 0.528, 
p<0.001 for FBS and 0.510, p<0.001 for PPBS. Regression analysis 
showed a significant relation between fasting and postprandial 
sugar level with glycosylated hemoglobin levels (p<0.001). For 
validating this regression test, Receiver operating characteristic 
(ROC) curve was plotted (fig. 1). The results showed that the 
sensitivity, specificity, positive predictive value and negative 
predictive value of postprandial glucose level were better than the 
fasting blood glucose level (table 2). 
  
Table 2: Comparison of fasting blood sugar (FBS) and postprandial blood sugar (PPBS) to determine glycemic control 
  FBS  PPBS  p value 
Sensitivity (%)  53.5  66.3  
<0.001* Specificity (%)  71.9  73.2 
Positive predictive value (%)  39.9  48 
Negative predictive value (%)  81.6  85.3 
Area under ROC curve (AUC) (%)  71.7  73.7 
 Good glycemic control: HbA1c ≤ 7%; *p value<0.05(significant) 
 
 
Fig. 1: Receiver operating characteristic (ROC) curve plot for 
FBS, PPBS and HbA1c (reference line) 
DISCUSSION 
People with diabetes have a greater risk of developing a number of 
major health problems. Consistently high blood glucose levels can 
lead to macrovascular and microvascular complication that will 
eventually affect patients’ quality of life [23]. The costs related to 
diabetes include increased use of health services, disability and 
productivity loss, which can be a considerable burden to the patient, 
families and society [24]. 
Proper glycemic control is the best strategy to prevent and delay the 
progression of diabetes complication and improve the quality of life [25]. 
In our study, it has been observed that the mean HbA1C level was 
significantly (p<.001) higher in female gender similar to results by 
Adham et al., which showed that males had been significantly lower 
mean HbA1c levels than females [26]. 
When comparing type of diabetic medication, that patient who was 
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treated with insulin and OHA as a combination therapy had 
significantly (p<.001) higher mean HbA1c value compared to 
patients who received mono-therapy. Similar findings were reported 
by Adham et al., Benoit et al. and Harrabi et al. [26-28]. 
Many studies have indicated the association between FBS and PPBS 
with HbA1c level [19, 22, 29, 30],we also found that mean FBS and 
PPBS level was significantly (p<.001) elevated in patients with poor 
glycemic control (HbA1c>7%) similar to the study reported by 
Khattab et al. [31]. 
Patients with poor glycemic control along with lifestyle modification, 
require more aggressive treatment with multi-dose insulin or a 
combination of insulin and OHA to achieve the optimal glycemic 
control [32]. 
In this study, moderate correlation was observed between HbA1c 
and fasting plasma glucose (r=0.528) and postprandial glucose 
(r=0.510), this finding is consistent with other studies reported by 
Sikaris et al. and Ketema et al. [33, 34]. 
The result showed that correlation between PPBS and HbA1c had 
greater sensitivity, specificity, positive predictive value and negative 
predictive value compared to fasting blood sugar. Our study 
revealed that both FBS and PPBS are important to achieve optimal 
glycemic control, but PPBS has a closer association with HbA1c and 
better predictor for overall glycemic control compared to FBS, which 
is similar to the studies reported by Rosediani et al., Abrahamson et 
al. and Monnier et al. [19, 35, 36]. 
CONCLUSION  
This present study showed that there is the significant correlation 
between PPBS and HbA1c values. Validation of these results in the 
large cohort of patients in multicenter study will make them 
generalizable. Since PPBS is performed routinely, its interpretation 
in terms of long term glycemic control will help clinicians to tailor 
their therapeutic strategies.  
Study limitations 
The number of patients with good glycemic control and poor 
glycemic control was not equal. 
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